NCT03426579 Correlation Between Sedation Depth Monitoring and Reflexes During Intravenous Anesthesia With Dexmedetomidine and Remifentanil in Children Undergoing Direct Laryngoscopy for Surgical Procedures
| NCT ID | NCT03426579 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Laryngoscopy |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2017-10-23 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2017-10-23 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the correlation between sedation depth monitoring obtained by NeuroSENSE ® NS 701 Monitor and reflexes during intravenous anesthesia in children undergoing direct laryngoscopy for surgical procedures.
Eligibility Criteria
Inclusion Criteria: scheduled for elective direct laryngoscopy with surgical intervention, written informed consent of their parents or legal guardian. Exclusion Criteria: refusal of informed consent, known allergy for dexmedetomidine or remifentanil at start of anesthesia pulse oxygen saturation (SaO2) lower than 85%
Contact & Investigator
Vera Saldien
PRINCIPAL INVESTIGATOR
University Hospital, Antwerp
Frequently Asked Questions
Who can join the NCT03426579 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 8 Years, studying Laryngoscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03426579 currently recruiting?
Yes, NCT03426579 is actively recruiting participants. Contact the research team at vera.saldien@uza.be for enrollment information.
Where is the NCT03426579 trial being conducted?
This trial is being conducted at Edegem, Belgium.
Who is sponsoring the NCT03426579 clinical trial?
NCT03426579 is sponsored by University Hospital, Antwerp. The principal investigator is Vera Saldien at University Hospital, Antwerp. The trial plans to enroll 10 participants.